Oral Chemolysis for a 20-Millimeter Uric Acid Stone
A 20-millimeter uric acid stone is large enough to make surgery straightforward and dissolution genuinely uncertain — but she has real reasons to want to avoid an operation if she can.
Teresa K., a 34-year-old marketing coordinator, is getting married in four months and has been counting down to a honeymoon trip she and her fiancé booked over a year ago. She came in after two weeks of intermittent right flank discomfort that she initially attributed to a long flight for work; imaging ordered by her primary care physician found a 20mm stone occupying much of the lower pole of her right kidney, non-obstructing, with no fever or infection. She has never had a kidney stone before, has no other medical problems, and her renal function today is normal. Plain radiography showed the stone as radiolucent, and her urine pH on repeat testing has run consistently at 5.3—5.5, well below the range where uric acid stays in solution; combined with a 24-hour uric acid excretion of 720mg/day, the clinical picture strongly favors a pure uric acid stone even before any surgical specimen exists to confirm it directly.
That combination of features — low pH, radiolucency, hyperuricosuria — is exactly the profile associated with the best outcomes in published oral chemolysis series, where the systematic review EAU cites reports complete or partial dissolution in 80.5% of appropriately selected patients, alongside factors like smaller stone size and lower density predicting which patients respond fastest. That figure is earned at a urine pH of 7.0 to 7.2, and the same guidance flags the cost of getting there: the more alkaline the urine, the better uric acid dissolves and the more readily calcium phosphate precipitates instead. At 20mm, though, Teresa's stone sits well above the size range most of that favorable literature is built on, and dissolution at this size typically takes longer and succeeds less reliably than it does for a stone half as large — a real tension between a strong composition match and a size that argues the other way, made sharper by a wedding and a booked trip sitting on her own calendar.
Her composition profile is close to what the literature treats as an ideal chemolysis candidate; her stone's size is close to what the same literature treats as a poor prognostic sign, independent of composition. What settles the shape of today's decision is not which of those matters more but the third number, the one that belongs to neither: the wedding is sixteen weeks out, and a dissolution attempt that has not visibly worked by six of them still leaves time to operate and recover. That is the window she is actually deciding inside, and it is wide enough to try and narrow enough that trying cannot be open-ended.
In clinic, reviewing her imaging
Her whole profile — low pH, radiolucent on plain film, real hyperuricosuria — is the exact picture that predicts the best chemolysis outcomes in the published series, over 80% complete or partial dissolution in well-selected patients. I'd start oral alkalinization now, titrated to a urine pH of 7.0 to 7.2 — that is the dissolution window, not the 6.5 we'd settle for if we were only trying to stop her forming another one — with imaging at four to six weeks to confirm it's actually shrinking.
I agree her composition profile is close to ideal. But size is its own independent predictor in these series, separate from composition — larger stones consistently take longer and dissolve less completely than smaller ones with the same chemistry, and 20mm is well above where most of that favorable data comes from.
A profile that predicts success doesn't erase a factor that predicts a slower, less certain course — both are true about the same stone at once, and I don't think her composition match should be read as settling the size question.
Given she has a real date on the calendar, I'd propose committing to a hard six-week window for chemolysis with imaging at that point, and reserving a percutaneous nephrolithotomy slot now as backup rather than waiting to see if she needs one. That way trying the less invasive option first doesn't cost her the scheduling flexibility she actually needs before the wedding.
Agreed: a firm six-week trial of oral alkalinization with a pre-reserved percutaneous nephrolithotomy slot as backup, repeat imaging at the six-week mark to decide definitively.
Not agreed: the endourologist would have preferred proceeding directly to a scheduled procedure given the stone's size, and agreed to the trial period mainly because a backup slot removed his main objection about losing time if it failed.